Cannabis Wealth, Newcastle upon Tyne (2025)

14/02/2023

Kanabo Group has confirmed that the process of obtaining European CE approval for its unique meter-dose cannabis inhaler is continuing to progress.

CEO of Kanabo, Avihu Tamir, commented: “I am proud of our achievements in 2022, and believe we are now well-positioned to look forward with confidence as we head into 2023 to deliver a more accessible healthcare experience for patients."

Kanabo Group has confirmed that the process of obtaining European CE approval for its unique meter-dose cannabis inhaler is continuing to progress.

13/02/2023

Cannadips Europe, a SpectrumLeaf brand, has partnered up with Haypp Group which will soon offer the Cannadips Terpene Pouch Collection via its online platform.

CEO of SpectrumLeaf, Felix Sundström, commented: “Haypp is the perfect partner to further grow Cannadips and put it on the global stage, as we have the same objectives to offer healthier alternatives to users."

CBD company Cannadips Europe, a SpectrumLeaf brand specialising in premium CBD Snus products for the European market, has partnered up with Haypp Group - a company that is spearheading the global transformation from smoking to healthier product alternatives.

09/02/2023

The UK’s Cannabis Industry Council is urging the Treasury to “unlock the very significant economic potential” of the medical cannabis, h**p and CBD wellbeing sectors.

Mike Morgan-Giles, CEO of the Cannabis Industry Council, commented: “Despite the economic opportunity for the UK, it appears no cross-government plan covering the potential of the cannabis sector has taken place. Additionally, there has not been any top-level view or analysis of how the regulatory environment is impacting the sector.

“The UK needs to seize the opportunity to lead the world in emerging economic markets and the medical cannabis, CBD, and h**p sectors provide an unmissable opportunity to do that.”

The UK’s Cannabis Industry Council is urging the Treasury to “unlock the very significant economic potential” of the medical cannabis, h**p and CBD wellbeing sectors.

08/02/2023

Bloomwell Group has raised funding from Artemis Growth Partners, Measure 8 Venture Partners, and Moritz Bleibtreu, which will all be joining the company’s mission to de-stigmatise cannabis use for patients and for future adult-use consumers.

Co-Founder and CEO of Bloomwell Group, Niklas Kouparanis, commented: “...we are humbled to not only have the continued support of our existing investors but also to have been able to attract new lead capital from such a highly reputable group as Artemis, which is a statement of confidence and vision that we accept and embrace."

Bloomwell Group has raised funding from Artemis Growth Partners, Measure 8 Venture Partners, and a leading German family office Moritz Bleibtreu which will all be joining the company’s mission to de-stigmatise cannabis use for patients and for future adult-use consumers.

07/02/2023

Ananda Developments Plc has confirmed it has completed the testing of its 2022 harvested cultivars, demonstrating successful growth of diverse strains.

Ananda Developments has confirmed it has completed the testing of its 2022 harvested cultivars, demonstrating successful growth of diverse strains.

06/02/2023

Akanda Corp. has confirmed it has successfully launched its initial supply of products to German customers, recognising approximately €1.8 million in sales of EU GMP high-quality indoor-grown in the last quarter of 2022.

Chairman at Akanda, Harvinder Singh, commented: “Our vision is to be a pioneer in the European cannabis markets, utilising our valuable global expertise in cutting-edge cannabis cultivation processes.”

Akanda has confirmed it has successfully launched its initial supply of products to German customers, recognising approximately €1.8 million in sales of EU GMP high-quality indoor-grown medical cannabis in the last quarter of 2022.

03/02/2023

Prohibition Partners has released The European CBD Report: Health & Wellness which is designed to bring readers up to speed on CBD legislation, regulations and enforcement; how to operate a compliant CBD business and the current supply chain and consumer behaviour.

Find out more. ⬇

Prohibition Partners expects to see fully legal CBD food products being sold on the shelves of major retailers in every country in Europe in the next two to five years.

02/02/2023

Sana Healthcare will be renamed Script Assist after the company’s innovative platform which provides clinicians with everything they need to prescribe independently from their existing private clinic.

“Today is the culmination of years of hard work and I’m proud to be re-branding Sana Healthcare as Script Assist, our flagship platform that I’m sure will have a huge impact on cannabis prescribing in the UK”, founder Arjun Rajyagor said.

Sana Healthcare will be renamed Script Assist after the company’s innovative platform which provides clinicians with everything they need to prescribe medical cannabis independently from their existing private clinic.

01/02/2023

High Tide Inc. has signed an LOI with Berlin-based health and life science company Sanity Group to better take advantage of potential German adult-use cannabis legalisation.

Founder and CEO of High Tide, Raj Grover, stated: “We want to be well positioned to bring this success to the German market, should the government proceed with its publicly stated goal to legalise cannabis adult use.

“This is why we are proud to partner with a top player in the German medical cannabis space like Sanity Group, particularly since our business models are complementary in nature.”

High tide has signed an LOI with Berlin-based health and life science company Sanity Group to better take advantage of potential German adult-use cannabis legalisation.

31/01/2023

Aleafia Healthealth has announced that it has signed a new European distribution partner, significantly bolstering its record USD$1.2 million year-to-date sales in its growing international channel.

Aleafia CEO Tricia Symmes commented: “The company is involved in overseas markets because international success leverages both its products and brands, and the addressable European cannabis market is high potential, so this relationship provides another gateway into further European expansion in the medical and potential recreational markets.”

Aleafia Health has announced that it has signed a new European cannabis distribution partner, significantly bolstering its record USD$1.2 million year-to-date sales in its growing international channel.

30/01/2023

Akerna Corp. has announced it will merge with privately held bitcoin mining company, Gryphon Digital Mining, in an all-stock deal that will advance Gryphon’s leading ESG-committed, carbon-neutral business.

Akerna Corp. has announced it will merge with privately held bitcoin mining company, Gryphon Digital Mining, in an all-stock deal that will advance Gryphon’s leading ESG-committed, carbon neutral bitcoin mining business.

27/01/2023

The U.S. Food and Drug Administration (FDA) has announced it will be creating a new regulatory path for as current regulations are not suitable.

FDA Principal Deputy Commissioner Janet Woodcock, M.D., states in a press release on the day of the announcement: “Today we are announcing that after careful review, the FDA has concluded that a new regulatory pathway for CBD is needed that balances individuals’ desire for access to CBD products with the regulatory oversight needed to manage risks."

The U.S. Food and Drug Administration (FDA) has announced it will be creating a new regulatory path for CBD products as current regulations are not suitable.

26/01/2023

CBD brand, EthicaCBD, has announced its partnership between its Sports Gel and sporting legend Sir Ian Botham OBE.

The core ingredients of the sports gel are two cannabinoids - CBD and CBG.

CBD brand, EthicaCBD has announced its partnership between its Sports Gel and sporting legend Sir Ian Botham OBE.

25/01/2023

CleverLeaves has announced the wind-down of all operations in Portugal, expecting its Portuguese flower cultivation, post-harvest processes, and manufacturing activities to cease in full by the end of the first quarter of 2023.

CEO of Clever Leaves, Andres Fajardo, commented: “We believe this transition will allow us to optimise our production infrastructure and drive increased cost savings, positioning us to compete more effectively in the global market.

Clever Leaves has announced the wind-down of all operations in Portugal, expecting its Portuguese flower cultivation, post-harvest processes, and manufacturing activities to cease in full by the end of the first quarter of 2023.

24/01/2023

Hilltop Leaf Ltd has confirmed it has raised £2m which will enable the company to make its first commercial sales and scale its infrastructure to become one of the largest UK producers of products.

CEO of Hilltop Leaf, Hamish Clegg, said: “We aim to provide an affordable, high-quality solution to treat conditions ranging from chronic pain to severe epilepsy, while easing pressure on the NHS. We plan to rival other countries such as Canada, Germany and Israel with our own reliable supply from the hills of Scotland.”

Hilltop Leaf has confirmed it has raised £2m from Traditum Private Equity and private investors.

23/01/2023

This year’s The Grocer Awards 2022 included by BRITISH CANNABIS™ Dermal Patches as one of the New Products of The Year at their annual event, Hilton Bankside, London.

“We are very proud to have our product selected amongst a host of well-known manufacturers and included in the rising star brands of consumer products at the event," commented Marketing Director Steve Batchelor.

The ‘Rising New Product’ was selected to join a shortlist of finalists in the Personal Care Category by a panel of expert judges drawn from a range of disciplines in the FMCG fields.

20/01/2023

BRITISH CANNABIS™ ACCESS CBD® was voted Best CBD Oil in Pharmacy (For Sleep Issues, stress & insomnia) for the second time through P3 Pharmacy Magazine.

British Cannabis™ Marketing Director Steve Batchelor commented: “It is increasingly difficult for brands to break through the clutter and succeed. This is where The MVP P3 Awards help the latest products stand out from the competition and brands gain an edge in the market."

Winners were revealed during a Celebratory Gala Lunch where BRITISH CANNABIS™ ACCESS CBD® was voted Best CBD Oil in Pharmacy (For Sleep Issues, stress & insomnia) for the second time.

19/01/2023

Linnea SA has been granted a narcotics license by Swissmedic making it one of the first companies in Switzerland to be able to produce and export high THC APIs.

CEO of Linnea SA, Susanne Caspar, commented: “We are so honoured to be granted a narcotics license in Switzerland, this opens up many new commercial possibilities for Linnea Cannabinoids and our customers."

Linnea SA has been granted a narcotics license by Swissmedic making it one of the first companies in Switzerland to be able to produce and export high THC Active Pharmaceutical Ingredients (APIs).

Cannabis Wealth